R. C. Doiron, J. C. Nickel, and S. Kamdar, “The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women: A cost-utility analysis”, CUAJ, vol. 20, no. 5, pp. E154–62, Jan. 2026.